Nippon India Quant Fund - Direct Plan Growth Plan - Growth Option vs UTI Healthcare Fund - Direct Plan - Growth Option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Nippon India Quant Fund - Direct Plan Growth Plan - Growth Option appears stronger overall due to its higher star rating of 4 compared to UTI Healthcare Fund's rating of 2, indicating better management and performance consistency. However, while UTI Healthcare Fund shows significantly higher short-term returns over the past year and impressive 3-year CAGR, it comes with a higher expense ratio and a much smaller AUM, which may raise concerns about liquidity and stability. For investors choosing between these two, consider whether you prioritize higher returns and accept the risks associated with a smaller fund, or prefer a more established fund with a stronger rating.
Nippon India Quant Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
★★★★★
Equity · Sectoral/ Thematic
UTI Healthcare Fund - Direct Plan - Growth Option
UTI Mutual Fund
★★★★★
Equity · Sectoral/ Thematic
| Metric | Nippon India Quant Fun... | UTI Healthcare Fund - ... |
|---|---|---|
| NAV | ₹81.48 | ₹388.33 |
| Star Rating | ★★★★ | ★★ |
| Expense Ratio | 0.79% | 0.89% |
| AUM | ₹50,176 Cr | ₹276 Cr |
| 1M Return | +7.6% | +3.56% |
| 3M Return | +0.31% | +0.97% |
| 6M Return | +6.48% | +15.53% |
| 1Y Return | +1.7% | +17.23% |
| 3Y CAGR | +14.0% | +24.41% |
| 5Y CAGR | +13.5% | +16.89% |
| Risk Level | — | — |
| Fund Manager | Manish Gunwani | Pradeep Gokhale |